Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
Filter results
You can narrow down the results using the filters
Topic
- Medical devices (59)
- Scheduling (52)
- OTC medicines (12)
- Prescription medicines (8)
- Complementary medicines (7)
- Labelling and packaging (4)
- Legislation (4)
- Medicines (4)
- Advertising (3)
- Advisory bodies and committees (3)
- Biologicals (3)
- Therapeutic goods regulation (3)
- Fees and payments (2)
- Listed medicines (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Clinical trials (1)
- Import and export (1)
- Manufacturing (1)
- Medical devices safety (1)
- Medicinal cannabis hub (1)
- Medicines safety (1)
- Nicotine vaping products hub (1)
- Other therapeutic goods (1)
- Safety (1)
- Sunscreens (1)
- Unique Device Identification (UDI) Hub (1)
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Read the details of recent consultations, submissions and decisions at the TGA Consultation hub.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Search
188 result(s) found, displaying 26 to 50
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, November 2021Proposed amendments to the Poisons Standard. Closing date: 7 October 2021
- Closed onConsultationConsultation on Draft Guidance: Assistive Technologies and the Therapeutic Goods (Excluded Goods) Determination 2021The consultation period on changes to the assistive technologies exemption has been extended to 22 October 2021.
- Closed onConsultationConsultation: Proposed refinements to the requirements for medical device patient information materialsThe public consultation for the Proposed refinements to the requirements for medical device patient information materials.
- Closed onConsultationConsultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): MelatoninOutcomes of the consultation and submissions received have now been published
- Closed onConsultationConsultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): TriptansOutcomes of the consultation and submissions received have now been published
- Closed onConsultationConsultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): MometasoneOutcomes of the consultation and submissions received have now been published
- Closed onConsultationConsultation: Proposed minor changes to Required Advisory Statements for Medicine Labels (RASML): Chlorhexidine, hydrocortisone, ibuprofenOutcomes of the consultation and submissions received have now been published
- Closed onConsultationConsultation: Proposed changes to the Permissible Ingredients Determination: Low-negligible risk changes 2021-22The outcome of the Listed medicines ingredient low-negligible risk changes 2021-22 have been published
- Closed onConsultationConsultation: Proposed refinements to the regulation of medical devices that are substances introduced into the human body via a body orifice or applied to the skinSubmissions published and summarised as part of a consultation on medical devices that are substances for introduction into the body.
- Closed onConsultationConsultation: Proposed refinements to the regulation of personalised medical devicesThe closing date has been extended and now closes on 14 July
- Closed onConsultationConsultation: Remaking of standards and legislative instruments for human cell and tissue (HCT) products, blood and blood componentsThe TGA is seeking feedback on a proposal to remake some of the legislative instruments relating to human cell and tissue (HCT) products (including blood and blood components), which sunset in October 2021. Closing date: 11 July 2021
- Closed onConsultationConsultation: Proposed improvements to the Therapeutic Goods Advertising CodeThe outcomes of the public consultation into proposed improvements to the Therapeutic Goods Advertising Code have been published.
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - ACCS #31, June 2021Proposed amendments to the Poisons Standard. Closing date: 4 June 2021
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - Joint ACMS/ACCS #28, June 2021Proposed amendments to the Poisons Standard, including substances in hand sanitisers. Closing date: 27 May 2021
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - ACMS #34, June 2021Proposed amendments to the Poisons Standard. Closing date: 27 May 2021
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard (oral contraceptives) - ACMS #34, June 2021Proposed amendments to the Poisons Standard. Closing date: 27 May 2021
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard (sodium nitrite) - Joint ACMS/ACCS #28, June 2021The closing date for this consultation has been extended until 27 May 2021
- Closed onConsultationConsultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Methyl salicylateThe TGA is seeking feedback on proposed advisory statements for OTC medicines containing methyl salicylate for inclusion in RASML. Closing date: 18 May 2021
- Closed onConsultationConsultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Lidocaine (lignocaine)Outcomes of the consultation and submissions received have now been published
- Closed onConsultationConsultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Sedating antihistaminesOutcomes of the consultation and submissions received have now been published
- Closed onConsultationConsultation: Proposed changes to Required Advisory Statements for Medicine Labels (RASML): MentholOutcomes of the consultation and submissions received have now been published
- Closed onConsultationConsultation: Building a more robust medicine supply - proposals to help prevent, mitigate and manage medicine shortagesView the outcomes of public consultation on building a more robust medicine supply
- Closed onConsultationIMDRF consultation: Assessment and Decision Process for the Recognition of a Conformity Assessment Body Conducting Medical Device Regulatory ReviewsThe IMDRF working group is seeking comments from interested parties on the proposed guidance document. Closing date: 19 April 2021
- Closed onConsultationConsultation: Proposal for clarifying regulatory requirements for residual claims for disinfectantsThis consultation is to obtain feedback in relation to proposals to provide clarity on residual claims for disinfectants. Closing date: 26 March 2021
- Closed onConsultationConsultation: Proposed regulatory options for medical devices containing nanomaterialsTGA is seeking comments on whether the Australian medical device regulatory framework should be aligned to the EU framework for medical devices containing nanomaterials. Closing date: 9 April 2021